Acute hippocampal slice (n = 4 Wistar rats, post-natal day 25-30).
3hrs exposure to 2µM amyloid-beta.
Field excitatory post-synaptic potential (fEPSP) recordings.
Stimulating CA3/Schaffer Collaterals; recording from CA1 field.
(left) Evoked fibre volley (FV) amplitude as a function of stimulation magnitude.
(right) Evoked fEPSP slope as a function of stimulation magnitude.
Analysis by simple linear regression.
β-Amyloid Peptide (1-42) (human) (HB9805) testing
Acute hippocampal slice (n = 4 Wistar rats, post-natal day 25-30).
3hrs exposure to 2µM amyloid-beta.
Field excitatory post-synaptic potential (fEPSP) recordings.
Stimulating CA3/Schaffer Collaterals; recording from CA1 field.
(left) Evoked fibre volley (FV) amplitude as a function of stimulation magnitude.
(right) Evoked fEPSP slope as a function of stimulation magnitude.
Analysis by simple linear regression.
References are publications that support the biological activity of the product
Amyloid-peptide β 42 Enhances the Oligomerization and Neurotoxicity of apoE4: The C-terminal Residues Leu279, Lys282 and Gln284 Modulate the Structural and Functional Properties of apoE4